All-new VC Sheet coming soon. Get early access
You're in!
We'll reach out soon.
Oops! Something went wrong while submitting the form.

Cellular Longevity

Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too. By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species. At Loyal, our first products to market are focused on longevity and healthspan in dogs. Join us in our mission to help dogs everywhere.
Founding Year
2020
Headquarters
San Francisco
,
United States
Sector(s)
No items found.
Funding State
Pre-Seed
Seed
Series A
Series B+
Exited
Total Funding Amount
$140.12M
Funds that Investested

The Longevity Fund

$37M Seed and Series A fund investing in founders developing therapeutic breakthroughs for age-related disease.
Pre-Seed
Seed
Series A
Series B+
View Profile

BoxGroup

BoxGroup is an early-stage investment fund that invests in technology companies.
Pre-Seed
Seed
Series A
Series B+
View Profile

Quiet Capital

Move the world further, faster, with quiet capital by investing in technology businesses early to create long-term value.
Pre-Seed
Seed
Series A
Series B+
View Profile

First Round Capital

Called First Round for a reason. Your first money in is one thing. But so are your first hires, your first product and your first customers. They've helped Notion, Roblox, Uber, Square, and 300 others tackle these firsts and more. First round is building the world’s best product for founders who are just getting started.
Pre-Seed
Seed
Series A
Series B+
View Profile

The Todd & Rahul Angel Fund

Pre-Seed
Seed
Series A
Series B+
View Profile

Browder Investments

Pre-Seed
Seed
Series A
Series B+
View Profile

Bain Capital Ventures

Invests in seed to growth-stage startups that uses tech to disrupt existing markets or create entirely new ones.
Pre-Seed
Seed
Series A
Series B+
View Profile

Khosla Ventures

Broadly, a venture we back offers one or more of the factors: 1. Significant technology or business model innovation 2. “Black Swan” ideas with significant upside or a significantly better mousetrap 3. Large markets, either existing or newly enabled by the innovation at hand 4. Short innovation cycles 5. Upfront risk
Pre-Seed
Seed
Series A
Series B+
View Profile
Investors that Investested
No items found.

Browse All Sheets

Find lists for every type of VC
By Round
By Geography
By Sector
By Type
Sector-focused Sheets